What changed
What changedOn November 5, 2026, HCA Inc. completed a public offering of seven series of senior notes, fully guaranteed by the parent company, HCA Healthcare, Inc. This debt issuance was formalized through a series of supplemental indentures, changing the company's long-term debt structure.

What changedHCA Healthcare reported third-quarter 2026 results: revenue was $19.8 billion and net income was $1.6 billion. Simultaneously, subsidiary HCA Inc. initiated a new offering of unsecured notes and announced plans to redeem $1.2 billion of debt due in February 2027.

Sector peers
How this company compares with 36 covered companies in Health Care (median revenue change +7.2% YoY), from archived SEC XBRL filings.
Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.
Governance events
Filings about how the company is run: auditor changes, restatements, leadership changes, late filings, delistings, Schedule 13D stakes and SEC comment letters, newest first.
As filed with the SEC, read by code. A comment letter is part of the SEC staff’s routine review and does not by itself mean a problem; item 5.02 covers appointments as well as departures; Form 25 may concern a bond or another class of securities.
Insider trades
| Date | Person | Trade | Shares | Avg. price | Value | Filing |
|---|
| November 10, 2026 | Erica Rossitto | Sale | 3,500 | $505.81 | $1,770,335 | SEC |
| November 6, 2026 | Jon M Foster | Sale | 31,713 | $500.98 | $15,887,482 | SEC |
| November 4, 2026 | Michael J Schlosser | Sale | 1,200 | $494.65 | $593,583 | SEC |
All insider trades →
Large funds (13F)
| Fund | Shares | Value | Change in shares | Quarter |
|---|
| BlackRock | 12,429,816 | $5,304,299,583 | -4.4% | Q3 2026 |
| State Street | 6,991,079 | $2,983,373,052 | -6.4% | Q3 2026 |
| Wellington Management | 4,302,740 | $1,836,151,270 | -8.6% | Q3 2026 |
| Geode Capital Management | 3,506,378 | $1,489,380,591 | -4.4% | Q3 2026 |
| Norges Bank (Norway's sovereign fund) | 2,145,367 | $836,457,140 | — | Q2 2026 |
| Fidelity (FMR) | 1,472,261 | $628,272,750 | -9.8% | Q3 2026 |
| Bridgewater Associates | 202,141 | $86,261,650 | -0.5% | Q3 2026 |
| Millennium Management | 165,181 | $70,489,340 | +158.4% | Q3 2026 |
| D. E. Shaw & Co. | 152,696 | $65,161,492 | +9.5% | Q3 2026 |
| Citadel Advisors | 102,951 | $43,933,309 | -44.2% | Q3 2026 |
| Renaissance Technologies | 18,600 | $7,251,954 | — | Q2 2026 |
| Two Sigma Investments | 12,187 | $5,200,680 | +897.3% | Q3 2026 |
| T. Rowe Price | 237,968 | $101,552 | -7.0% | Q3 2026 |
From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.